Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 3VIL | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with salicin | |
| 3VIM | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with a new glucopyranosidic product | |
| 3VIN | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with a new glucopyranosidic product | |
| 6XRX | Q8T5C5 | Crystal structure of the mosquito protein AZ1 as an MBP fusion | |
| 6NRW | Q8T603 | Crystal structure of Dpr1 IG1 bound to DIP-eta IG1 | |
| 4G2U | Q8T8F4 | Crystal Structure Analysis of Ostertagia ostertagi ASP-1 | |
| 3K1L | Q8T913 | Crystal Structure of FANCL | |
| 4JNO | Q8T9N3 | Crystal structure of Plasmodium falciparum Erythrocyte Binding Antigen 140 (PfEBA-140/BAEBL) Region II in complex with sialyllactose | BAEBL protein |
| 6VFU | Q8TAB3 | Crystal structure of human protocadherin 19 EC1-EC4 | |
| 5TIB | Q8TAX9 | Gasdermin-B C-terminal domain containing the polymorphism residues Arg299:Ser306 fused to maltose binding protein | |
| 5TJ2 | Q8TAX9 | Gasdermin-B C-terminal domain containing the polymorphism residues Gly299:Ser306 fused to maltose binding protein | |
| 5TJ4 | Q8TAX9 | Gasdermin-B C-terminal domain containing the polymorphism residues Gly299:Pro306 fused to maltose binding protein | |
| 7CZQ | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P2B-1A10 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 7CZU | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 6DCQ | Q8TCD0 | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain |
| 6DCQ | Q8TCD0 | Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab | Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain |
| 7CZR | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 6ARU | Q8TCD0 | Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain | |
| 6ARU | Q8TCD0 | Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain | |
| 6NZ7 | Q8TCD0 | Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968 | Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, 429 B01 FAB heavy chain, 429 B01 FAB light chain |
| 6NZ7 | Q8TCD0 | Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968 | Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, 429 B01 FAB heavy chain, 429 B01 FAB light chain |
| 7CZS | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 5VOD | Q8TCD0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
| 5VOD | Q8TCD0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
| 5W42 | Q8TCD0 | Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2) | |
| 5W42 | Q8TCD0 | Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2) | |
| 6E4X | Q8TCD0 | Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2) | Hemagglutinin HA1, Lineage K03.12 UCA antibody heavy chain, Lineage K03.12 UCA antibody light chain |
| 6E4X | Q8TCD0 | Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2) | Hemagglutinin HA1, Lineage K03.12 UCA antibody heavy chain, Lineage K03.12 UCA antibody light chain |
| 7CZV | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VL3 | Q8TCD0 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain |
| 5VL3 | Q8TCD0 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain |
| 6BKC | Q8TCD0 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
| 6BKC | Q8TCD0 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
| 6DC5 | Q8TCD0 | RSV prefusion F in complex with AM22 Fab | |
| 6DC5 | Q8TCD0 | RSV prefusion F in complex with AM22 Fab | |
| 7D00 | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 1HZH | Q8TCD0 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
| 1HZH | Q8TCD0 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
| 3PGF | Q8TCD0 | Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB) | |
| 3PGF | Q8TCD0 | Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB) | |
| 7CZX | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B9 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 6K2Z | Q8TCE9 | Human Galectin-14 with lactose | |
| 6S7T | Q8TCJ2 | Cryo-EM structure of human oligosaccharyltransferase complex OST-B | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (E.C.2.4.99.18), Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4, Transmembrane protein 258, Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1, Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1, Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2, Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit, Magnesium transporter protein 1, Malectin, PEPTIDE |
| 6AYF | Q8TDD5 | TRPML3/ML-SA1 complex at pH 7.4 | |
| 8IHB | Q8TDS4 | Cryo-EM structure of HCA2-Gi complex with GSK256073 | |
| 8IHF | Q8TDS4 | Cryo-EM structure of HCA2-Gi complex with MK6892 | |
| 8IHH | Q8TDS4 | Cryo-EM structure of HCA2-Gi complex with LUF6283 | |
| 8IHI | Q8TDS4 | Cryo-EM structure of HCA2-Gi complex with acifran |
